|
1
|
Du BL: Esophageal Carcinoma. Beijing:
China Science and Technology Press; pp. 30–60. 1994
|
|
2
|
Wang LD, Gao WJ, Yang WC, et al: Prelimary
analysis of the statistics on 3933 cases with esophageal cancer and
gastric cardia cancer from the subjects in the People’s Hospital of
Linzhou in 9 years. J Henan Med Univ. 32:9–11. 1997.(In
Chinese).
|
|
3
|
Lu JB, Yang WX, Zu SK, et al: Cancer
mortality and mortality trends in Henan, China, 1974–1985. Cancer
Detect Prev. 13:167–173. 1988.
|
|
4
|
Shi QL, Xu DZ and Sun C: Study on family
aggregation of esophageal cancer in Linzhou city. Zhonghua Yu Fang
Yi Xue Za Zhi. 34:269–270. 2000.(In Chinese).
|
|
5
|
Hu N, Dawsey SM, Wu M, et al: Familial
aggregation of oesophageal cancer in Yangcheng County, Shanxi
Province, China. Int J Epidemiol. 21:877–882. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carter CL, Hu N, Wu M, et al: Segregation
analysis of esophageal cancer in 221 high-risk Chinese families. J
Natl Cancer Inst. 84:771–776. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu N: Genetic epidemiclogy of esophageal
cancer: 10-year follow-up of 622 positive families in Yangcheng
County. Zhonghua Yi Xue Za Zhi. 70:679–681. 1990.(In Chinese).
|
|
8
|
Zhou HY, Liang M, Li SJ, Gao XK and Tao
DM: The study of four chromosomal fragile site of high incidence
familial esophageal cancer. Chinese Journal of Medical Genetics.
4:113–115. 1995.
|
|
9
|
Liu YL, Li XM, Jin GL, et al: The study of
FHIT expression and HPV testing in high incidence esophageal
squamous cell carcinoma in Ci County Hebei Province. Cancer.
22:492–494. 2003.
|
|
10
|
Greenspan DL, Connolly DC, Wu R, et al:
Loss of FHIT expression in cervical carcinoma cell lines and
primary tumors. Cancer Res. 57:4692–4698. 1997.PubMed/NCBI
|
|
11
|
Goode EL, Ulrich CM and Potter JD:
Polymorphisms in DNA repair genes and associations with cancer
risk. Cancer Epidemiol Biomarkers Prev. 11:1513–1530.
2002.PubMed/NCBI
|
|
12
|
Karran P, Offman J and Bignami M: Human
mismatch repair, drug-induced DNA damage, and secondary cancer.
Biochimie. 85:1149–1160. 2003. View Article : Google Scholar
|
|
13
|
Wang LD, Shi ST, Zhou Q, et al: Changes in
p53 and cyclin D1 protein levels and cell proliferation in
different stages of human esophageal and gastric-cardia
carcinogenesis. Int J Cancer. 59:514–519. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Giarnieri E, Mancini R, Pisani T,
Alderisio M and Vecchione A: Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax
Expression in invasive and in situ squamous cell carcinoma of the
uterine cervix. Clin Cancer Res. 6:3600–3606. 2000.PubMed/NCBI
|
|
15
|
Hao D, Wang G, Yin Z, et al: Systematic
large-scale study of the inheritance mode of Mendelian disorders
provides new insight into human diseasome. Eur J Hum Genet. Jan
22–2014.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cao X, Li LY, Xie J, Cao Y and Li Y: The
study of chromosome fragile site in esophageal cancer patients and
their first-degree relatives. Cancer. 15:349–351. 1996.
|
|
17
|
Huang J, Hu N, Goldstein AM, et al: High
frequency allelic loss on chromosome 17p13.3-p11.2 in esophageal
squamous cell carcinomas from a high incidence area in northern
China. Carcinogenesis. 21:2019–2026. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vaughn JP, Cirisano FD, Huper G, et al:
Cell cycle control of BRCA2. Cancer Res. 56:4590–4594.
1996.PubMed/NCBI
|
|
19
|
Hu N, Li G, Li WJ, et al: Infrequent
mutation in the BRCA2 gene in esophageal squamous cell carcinoma.
Clin Cancer Res. 8:1121–1126. 2002.PubMed/NCBI
|
|
20
|
Hu N, Wang C, Han XY, et al: Evaluation of
BRCA2 in the genetic susceptibility of familial esophageal cancer.
Oncogene. 23:852–858. 2004. View Article : Google Scholar
|
|
21
|
Bertrand P, Tishkoff DX, Filosi N,
Dasgupta R and Kolodner RD: Physical interaction between components
of DNA mismatch repair and nucleotide excision repair. Proc Natl
Acad Sci USA. 95:14278–14283. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pekarsky Y, Zanesi N, Palamarchuk A,
Huebner K and Croce CM: FHIT: from gene discovery to cancer
treatment and prevention. Lancet Oncol. 3:748–754. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ingvarsson S, Agnarsson BA,
Sigbjornsdottir BI, et al: Reduced Fhit expression in sporadic and
BRCA2-linked breast carcinomas. Cancer Res. 59:2682–2689.
1999.PubMed/NCBI
|
